Celltrion Healthcare IPO finally lifts off
The sales arm of drug maker Celltrion kicks off Korea's largest share sale this year hoping to match the success of other recent biopharma deals.
June 26, 2017
A clutch of South Korean biopharmaceutical companies plan to go public this year, raising capital to expand production capacity as the country strives to become a global powerhouse for the manufacture of biopharmaceutical products.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].